Creative Biolabs-Immuno-oncology

Anti-CCR6 (clone 459Q2E) SynExpress C-BF-I4-X Modified CD8+ T cells (CAT#: ITS-1224-CR344)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR6 (clone 459Q2E). We employs the Lentivirus (CMV-BFP-IL-4-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
mouse
Target
CCR6
Clone
459Q2E
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
Lentivirus
Transformation Accuracy
0.95
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.